| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |